Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Brief Report
Case Report
Case Report and Review
Case Series
Commentary
Editorial
How do I do it
How I do it?
Invited Editorial
Letter to Editor
Letter to the Editor
Letters to Editor
Letters to the Editor
Mini Review
Original Article
Original Articles
Others
Review Article
Short communication
Short Paper
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Brief Report
Case Report
Case Report and Review
Case Series
Commentary
Editorial
How do I do it
How I do it?
Invited Editorial
Letter to Editor
Letter to the Editor
Letters to Editor
Letters to the Editor
Mini Review
Original Article
Original Articles
Others
Review Article
Short communication
Short Paper
View/Download PDF

Translate this page into:

Case Report
8 (
1
); 55-57
doi:
10.4103/0974-2727.176225

Multidrug Resistant Shigella flexneri Infection Simulating Intestinal Intussusception

Department of Microbiology, Mahatma Gandhi Medical College and Research Institute, Puducherry, India
Address for correspondence: Dr. Arunava Kali, E-mail: ak.arunava@gmail.com
Licence

This is an open access article distributed under the terms of the Creative Commons Attribution NonCommercial ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non commercially, as long as the author is credited and the new creations are licensed under the identical terms.

Disclaimer:
This article was originally published by Medknow Publications & Media Pvt Ltd and was migrated to Scientific Scholar after the change of Publisher.

Abstract

Shigella enteritis remains an important cause of mortality and morbidity in all age groups, in developing as well as developed countries. Owing to the emerging resistance to multiple antibiotics among Shigella spp., it has been recognized as a major global public health concern and warrants constant monitoring of its resistance pattern. We report a case of segmental ileitis caused by non.-ESBL producing multidrug resistant Shigella flexneri in an infant clinically mimicking intussusception, which was effectively treated by ceftriaxone.

Keywords

Bacillary dysentery
multidrug resistant
Shigella flexneri

INTRODUCTION

Diarrhea is an important childhood infection globally, accounting for 2.5 million deaths in under-five children every year.[1] An intestinal infection caused by Shigella may have a wide range of clinical manifestations. Passage of blood and mucus in stool associated with high-grade fever, tenesmus, and intestinal cramps are common symptoms. Arthritis, conjunctivitis, parotitis, intussusception, rectal prolapse, and hemolytic uremic syndrome (HUS) may occur as complications, especially in the elderly, children, and immunocompromised patients.[2] Resistance to antibiotics such as ampicillin, co-trimoxazole, tetracycline, chloramphenicol, and aminoglycosides have become commonplace over decades.[3] Furthermore, resistance to third-generation cephalosporins, azithromycin, and fluoroquinolones are also on the raise.[45] This limits the antibiotic options available for empirical therapy, especially in children who also have a higher incidence of severe infections, complications, and mortality.[6] Here, we describe a case of bloody diarrhea in an infant caused by multidrug resistant Shigella flexneri, presenting with the clinical features simulating intussusception. Although the rapid evaluation with emergency abdominal ultrasonography was imperative to rule out intussusception, treatment with appropriate antibiotic resulted in the resolution of acute bloody diarrhea.

CASE REPORT

A 1-year-old male child was brought by parents to our hospital with several episodes of loose stools lasting 3 days with fever, vomiting, and abdominal pain. The stool was scanty in volume with mucus and blood. The fever was low-grade, not associated with chills and rigor. There was no history of similar episode of illness in the past. On examination, the baby was irritable and had moderate pallor and signs of mild dehydration. Abdominal examination revealed the soft abdomen with slight tenderness and mild hepatomegaly. Icterus, petechial rash, ecchymosis, splenomegaly, and joint tenderness were not detected. Emergency ultrasonography was done to rule out intussusception. It showed edematous loops of terminal ileum with few enlarged mesenteric lymph nodes and minimal free fluid in abdomen suggesting segmental ileitis. Hemogram showed hemoglobin 6.2 g/dl, total leukocyte count 15,300/cmm with 46% neutrophils, 50% lymphocytes, 3% monocytes, and 1% eosinophils. The platelet count, serum urea, creatinine, electrolytes, and bilirubin values were within normal range. Blood smear revealed normocytic/normochromic red blood cells (RBCs) without any acanthocytes, bite cells, and fragmented forms. Urine was normal in color and had no pus cells, RBCs, or hemoglobinuria. Intravenous (I.V.) rehydration therapy and antibiotics (ceftriaxone 350 mg I.V. 12 hourly) were started empirically. Packed cells transfusion was done to improve anemia on the same day. Although the frequency decreased, the child continued to pass loose mucoid greenish stools with streaks of blood. Further investigations were carried out to identify the etiology of bloody diarrhea. Urine and blood cultures were sterile. On microscopic examination, the stool was negative for ova, cyst, and trophozoites of intestinal parasites, and it showed 15–25 leukocytes and 10–15 RBCs per high-power field. A nonmotile, Gram-negative bacillus producing nonhemolytic colonies on blood agar and nonlactose fermenting colonies on MacConkey's agar was isolated from the stool. It was identified as S. flexneri based on biochemical reactions (catalase positive, indole negative, methyl red test positive, Voges-Proskauer test negative; citrate not utilized, urea not hydrolyzed; alkaline slant and acidic butt with no gas and no H2S production in triple sugar iron agar, glucose and mannitol fermented with acid only; lactose, sucrose and xylose not fermented; and lysine, arginine, and ornithine not decaboxylated). Serotyping confirmed it as S. flexneri 2a. The isolate showed susceptibility to ceftriaxone and gentamicin, but it was resistant to co-trimoxazole, chloramphenicol, tetracycline, ampicillin, furazolidone, nalidixic acid, and ciprofloxacin. Ceftriaxone (350 mg I.V. 12 hourly) was continued for 6 days along with intravenous fluids (for 2 days). It resulted in the resolution of symptoms of dysentery and general improvement of health. The baby was discharged on the 7th day with a plan to investigate the cause of anemia on subsequent visits. However, the patient was lost on follow-up.

DISCUSSION

Diarrhea is an important cause of childhood morbidity and mortality. Invasive infections (i.e. Shigella sp., enterohemorrhagic Escherichia coli (EHEC), Campylobacter jejuni, Yersinia enterocolitica, Aeromonas hydrophilia, Entamoeba histiolytica, and Trichuris trichiura infections) as well as noninfectious diseases such as inflammatory bowel disease (IBD), colitis associated with cow's milk, necrotizing enterocolitis, intussusception, and intestinal ischemia have been implicated in bloody diarrhea among children.[7] While abdominal ultrasonography and endoscopy are essential for the diagnosis of noninfectious causes, stool microscopy, and culture detect the pathogenic microorganism. Among these causes, shigellosis is, especially common in infants in developing countries.[7] In a study from North India, the most prevalent Shigella species among hospitalized children with diarrhea between 2001 and 2004 was S. flexneri (60%), followed by Shigella sonnei (23.8%), Shigella dysenteriae (9.8%), and Shigella boydii (5.7%).[8] S. flexneri, especially serotype 2a, was found to be the most common serotype among children in several other studies from the Indian subcontinent.[5] Grossly, bloody stools, dehydration, and seizures have been associated more frequently with Shigella species when compared with other intestinal bacterial pathogens.[9] Unlike S. dysenteriae type 1 and S. flexneri have been less frequently reported to cause severe extraintestinal as well as intestinal manifestations (i.e. intussusception and rectal prolapse).[2] In our case, abdominal cramp, vomiting, pallor, dehydration, and passage of bloody stool with mucus in the infant simulated the clinical picture of intussusception, mandating abdominal ultrasonography to rule it out. Surgical intervention for intussusception is indicated in case of bowel perforation and unsuccessful nonoperative reduction. As the baby was anemic, packed cells transfusion was given to prevent the complications of blood loss which might have occurred in the event of surgical reduction of intussusception. Since acute bloody diarrhea is unlikely to result in severe anemia, further investigations to rule out IBD, hook-worm infection, and other causes of severe anemia were scheduled during follow-up. However, the patient was lost during follow-up. HUS is a dreadful complication of Shigella and EHEC serotype O157:H7 infection, characterized by hemolytic anemia, thrombocytopenia, and acute renal failure.[10] In this patient, normal platelet counts, the absence of microangiopathic hemolytic anemia (acanthocytes, bite cells, and fragmented RBCs), and normal renal parameters were essential to rule out HUS.

Ampicillin, co-trimoxazole, and nalidixic acid were the treatment of choice for shigellosis in developing countries.[11] However, they have lost their clinical utility due to emerging antibiotic resistance. Hence, the third generation cephalosporins, azithromycin, and fluoroquinolones came up as alternatives.[12] Re-emergence of multidrug resistant S. dysenteriae type 1 strains during 2002 and S. flexneri type 2a since December 2003 with resultant year-wise increase in quinolone resistance from 15% in 2003 to 25% in 2004 have been reported from West Bengal.[8] Bhattacharya et al. have studied the trend of antimicrobial resistance in Shigella isolates from Andaman and Nicobar, which showed noticeable increase in resistance against ampicillin (72.7–100%), co-trimoxazole (57.6–80%), nalidixic acid (27.2–96%), ciprofloxacin (0 to 82%), and the third generation cephalosporins (0 to 12%) between 2000 and 2009.[3] Both plasmids-coded ESBLs of SHV-11 and CTX-M type and AmpC type beta-lactamases have been found in Shigella spp. to impart the third generation cephalosporin resistance.[512] In our case, although the S. flexneri isolate was multidrug resistant, it was not an ESBL producer. Therefore, prompt initiation of ceftriaxone along with good supportive care was effective in shortening the duration of symptoms and preventing complications.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

REFERENCES

  1. , , , , , , . High rate of resistance to locally used antibiotics among enteric bacteria from children in Northern Ghana. J Antimicrob Chemother. 2008;61:1315-8.
    [Google Scholar]
  2. , , , . Gastrointestinal and extra-intestinal manifestations of childhood shigellosis in a region where all four species of Shigella are endemic. PLoS One. 2013;8:e64097.
    [Google Scholar]
  3. , , , , , , . Antimicrobial resistance in Shigella – rapid increase and widening of spectrum in Andaman Islands, India. Indian J Med Res. 2012;135:365-70.
    [Google Scholar]
  4. , , , , , . Subtype prevalence, plasmid profiles and growing fluoroquinolone resistance in Shigella from Kolkata, India (2001-2007): A hospital-based study. Trop Med Int Health. 2010;15:1499-507.
    [Google Scholar]
  5. , , , , , , . Increasing spectrum in antimicrobial resistance of Shigella isolates in Bangladesh: Resistance to azithromycin and ceftriaxone and decreased susceptibility to ciprofloxacin. J Health Popul Nutr. 2007;25:158-67.
    [Google Scholar]
  6. , , , , , , . Prevalence and trends of aminoglycoside resistance in Shigella worldwide, 1999-2010. J Biomed Res. 2013;27:103-15.
    [Google Scholar]
  7. , . Management of bloody diarrhoea in children in primary care. BMJ. 2008;336:1010-5.
    [Google Scholar]
  8. , , , , , . Species diversity and antimicrobial resistance of Shigella spp. isolated between 2001 and 2004 from hospitalized children with diarrhoea in Kolkata (Calcutta), India. Epidemiol Infect. 2005;133:1089-95.
    [Google Scholar]
  9. , , , , , , . Incidence, clinical presentation, and antimicrobial resistance trends in Salmonella and Shigella infections from children in Yucatan, Mexico. Front Microbiol. 2013;4:288.
    [Google Scholar]
  10. , , , , , , . Clinical characteristics and antibiotic resistance of Shigella gastroenteritis in Ankara, Turkey between 2003 and 2009, and comparison with previous reports. Int J Infect Dis. 2011;15:e849-53.
    [Google Scholar]
  11. . . Guidelines for the Control of Shigellosis, Including Epidemics due to Shigella Dysenteriae Type 1. Geneva: World Health Organization; Available from: http://www.whqlibdoc.who.int/publications/2005/9241592330.p
  12. , , , , , , . Third-generation cephalosporin resistance in clinical isolate of Shigella sonnei in Andaman and Nicobar Islands, India. J Infect Dev Ctries. 2011;5:674-6.
    [Google Scholar]
Show Sections